Cargando…
Access to specialist cancer care: is it equitable?
The first principle of the Calman–Hine report's recommendations on cancer services was that all patients should have access to a uniformly high quality of care wherever they may live. This study aimed to assess whether the uptake of chemotherapy for colorectal cancer varied by hospital type in...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408901/ https://www.ncbi.nlm.nih.gov/pubmed/12439709 http://dx.doi.org/10.1038/sj.bjc.6600640 |
_version_ | 1782155717805867008 |
---|---|
author | Pitchforth, E Russell, E Van der Pol, M |
author_facet | Pitchforth, E Russell, E Van der Pol, M |
author_sort | Pitchforth, E |
collection | PubMed |
description | The first principle of the Calman–Hine report's recommendations on cancer services was that all patients should have access to a uniformly high quality of care wherever they may live. This study aimed to assess whether the uptake of chemotherapy for colorectal cancer varied by hospital type in Scotland. Hospitals were classified according to cancer specialisation rather than volume of patients. To indicate cancer specialisation, hospitals were classified as ‘cancer centres’, ‘cancer units’ and ‘non-cancer’ hospitals. Colorectal cancer cases were obtained from cancer registrations linked to hospital discharge data for the period January 1992 to December 1996. Multilevel logistic regression was used to model the binary outcome, namely whether or not a patient received chemotherapy within 6 months of first admission to any hospital. The results showed that patients admitted first to a ‘non-cancer’ hospital were less than half as likely to go on to receive chemotherapy as those first admitted to a cancer unit or centre (OR=0.28). This result was not explained by distance between hospital of first admission and nearest cancer centre, nor by increasing age or severity of illness. The study covers the period immediately preceding the introduction of the Calman–Hine report in Scotland and should serve as a baseline for future monitoring of access to specialist care. British Journal of Cancer (2002) 87, 1221–1226. doi:10.1038/sj.bjc.6600640 www.bjcancer.com © 2002 Cancer Research UK |
format | Text |
id | pubmed-2408901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-24089012009-09-10 Access to specialist cancer care: is it equitable? Pitchforth, E Russell, E Van der Pol, M Br J Cancer Clinical The first principle of the Calman–Hine report's recommendations on cancer services was that all patients should have access to a uniformly high quality of care wherever they may live. This study aimed to assess whether the uptake of chemotherapy for colorectal cancer varied by hospital type in Scotland. Hospitals were classified according to cancer specialisation rather than volume of patients. To indicate cancer specialisation, hospitals were classified as ‘cancer centres’, ‘cancer units’ and ‘non-cancer’ hospitals. Colorectal cancer cases were obtained from cancer registrations linked to hospital discharge data for the period January 1992 to December 1996. Multilevel logistic regression was used to model the binary outcome, namely whether or not a patient received chemotherapy within 6 months of first admission to any hospital. The results showed that patients admitted first to a ‘non-cancer’ hospital were less than half as likely to go on to receive chemotherapy as those first admitted to a cancer unit or centre (OR=0.28). This result was not explained by distance between hospital of first admission and nearest cancer centre, nor by increasing age or severity of illness. The study covers the period immediately preceding the introduction of the Calman–Hine report in Scotland and should serve as a baseline for future monitoring of access to specialist care. British Journal of Cancer (2002) 87, 1221–1226. doi:10.1038/sj.bjc.6600640 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-11-18 2002-11-12 /pmc/articles/PMC2408901/ /pubmed/12439709 http://dx.doi.org/10.1038/sj.bjc.6600640 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Pitchforth, E Russell, E Van der Pol, M Access to specialist cancer care: is it equitable? |
title | Access to specialist cancer care: is it equitable? |
title_full | Access to specialist cancer care: is it equitable? |
title_fullStr | Access to specialist cancer care: is it equitable? |
title_full_unstemmed | Access to specialist cancer care: is it equitable? |
title_short | Access to specialist cancer care: is it equitable? |
title_sort | access to specialist cancer care: is it equitable? |
topic | Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408901/ https://www.ncbi.nlm.nih.gov/pubmed/12439709 http://dx.doi.org/10.1038/sj.bjc.6600640 |
work_keys_str_mv | AT pitchforthe accesstospecialistcancercareisitequitable AT russelle accesstospecialistcancercareisitequitable AT vanderpolm accesstospecialistcancercareisitequitable |